Guided Therapeutics, Inc. is a medical technology company focused on developing innovative medical devices that improve healthcare. Its primary product is the LuViva Advanced Cervical Scan, a noninvasive cervical cancer detection device that uses biophotonics to scan the cervix with light and analyze reflected and fluorescent light. The device is designed to identify cervical cancers and precancers painlessly and at the point of care, offering a rapid alternative to…
Guided Therapeutics, Inc. is a medical technology company focused on developing innovative medical devices that improve healthcare. Its primary product is the LuViva Advanced Cervical Scan, a noninvasive cervical cancer detection device that uses biophotonics to scan the cervix with light and analyze reflected and fluorescent light. The device is designed to identify cervical cancers and precancers painlessly and at the point of care, offering a rapid alternative to conventional screening methods.
Guided Therapeutics generates revenue primarily through the sale of LuViva systems and the accompanying single‑use disposable cervical guides to distributors and directly to government health programs. The company also earns income from licensing agreements and collaborative arrangements that support research and development activities. Sales are made through a network of international distributors who market the device in their respective territories, while in some cases the company works directly with ministries of health to place units in national screening programs.
Guided Therapeutics occupies a niche position in the cervical cancer detection market as the only commercial stage company offering a biophotonic based noninvasive scan. It competes with established screening methods such as the Pap smear, HPV testing and colposcopy, as well as with emerging technologies from firms like Hologic’s Thin‑Prep, Qiagen’s HPV assay and Spectrascience’s device. The company’s competitive advantages stem from its ability to provide painless immediate results, to reduce the need for invasive follow‑up procedures and to lower overall screening costs, particularly in settings where medical infrastructure is limited.
The company serves a diverse customer base that includes international medical device distributors, government health agencies, non‑governmental organizations, hospitals and outpatient clinics. Specific partners mentioned in the filing include Shandong Medical Instrumentation Co. Ltd, Hangzhou Dongyue Medical Technology Co, Jiangsu Yuanshuo Medical Instruments Corporation, Newmars Technology, Inc. and various distributors operating in Turkey, Indonesia, Central and Eastern Europe and China. In addition, Guided Therapeutics works directly with the Turkish Ministry of Health and seeks collaborations with entities in India and the Persian Gulf region.